Clinical trial in Jersey aims to help heart failure patients
Key Points:
- Jersey has been selected to conduct a clinical trial testing new technology aimed at improving care for patients with Heart Failure with Preserved Ejection Fraction (HFpEF) through iron injections.
- Participants will wear a smart ring and a thigh patch for 14 weeks to continuously monitor physical activity and assess the treatment's effectiveness, providing more comprehensive data than traditional tests.
- Dr. Aaron Henry from Jersey Hospital highlights the importance of using continuous monitoring technology to gather detailed patient data, especially for elderly patients often excluded from tech advancements.
- CEO Tony Moretta emphasizes Jersey's role as an ideal location for pioneering digital health innovations, aiming to benefit the island through advancements in preventative healthcare.